Olivia Carr

Olivia Carr

Auto-generated profile, based on publicly available information

Olivia Carr

São Carlos Institute of Physics, University of São Paulo, São Carlos 13566-590, SP, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Talanta
Verified
Journal Article
Closed access
OCOlivia Carr
Olivia Carr
Paulo A. Raymundo-PereiraPaulo A. Raymundo-Pereira
Paulo A. Raymundo-Pereira
FSFlavio Shimizu
Flavio Shimizu
BSBruna Sorroche
Bruna Sorroche
MMMatias Eliseo Melendez
Matias Eliseo Melendez
OOOsvaldo Oliveira
Osvaldo Oliveira

6 March 2018 in Bulletin of the Chemical Society of Japan
Verified
Journal Article
Closed access
JMJaison C. Machado
Jaison C. Machado
FSFlavio Shimizu
Flavio Shimizu
MOManoel Ortiz
Manoel Ortiz
MPMarina S. Pinhatti
Marina S. Pinhatti
OCOlivia Carr
Olivia Carr
NVNadia M. Volpato
Nadia M. Volpato
Taste masking is an important strategy for improving adherence of patients, especially children, who have to take pharmaceutical drugs with a bitter taste, as is the case of praziquantel (PZQ) used to treat schistosomiasis. In this work, a modified interfacial polymer deposition method was used to prepare polymer microcapsules and microspheres to encapsulate PZQ, where formulations were optimized to fulfill the stringent requirements for controlled drug release. In vitro release tests confirmed the suitability of the formulation with microcapsules of the anionic copolymer L30D, in which the loading of PZQ was larger than 90% in solutions that were stable at low pH but released PZQ under enteric conditions. We also show that the encapsulation was effective in terms of masking PZQ taste through the analysis with an electronic tongue.

26 June 2020 in Cells
Verified
Journal Article
Open access
PDF file
JNJoão Batista Rocha Neto
João Batista Rocha Neto
Andrey Coatrini SoaresAndrey Coatrini Soares
Andrey Coatrini Soares
RBRogerio Bataglioli
Rogerio Bataglioli
OCOlívia Carr
Olívia Carr
CCCarlos Costa
Carlos Costa
Hernandes CarvalhoHernandes Carvalho
Hernandes Carvalho
The increasing need for point-of-care diagnosis has sparked the development of label-free sensing platforms, some of which are based on impedance measurements with biological cells. Here, interdigitated electrodes were functionalized with layer-by-layer (LbL) films of hyaluronan (HA) and chitosan (CHI) to detect prostatic tumor cells (PC3 line). The deposition of LbL films was confirmed with atomic force microscopy and polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS), which featured the vibrational modes of the HA top layer capable of interacting specifically with glycoprotein CD44 receptors overexpressed in tumor cells. Though the CHI/HA LbL films cannot be considered as a traditional biosensor due to their limited selectivity, it was possible to distinguish prostate tumor cells in the range from 50 to 600 cells/µL in in vitro experiments with impedance spectroscopy. This was achieved by treating the impedance data with information visualization methods, which confirmed the distinguishing ability of the films by observing the absence of false positives in a series of control experiments. The CD44–HA interactions may, therefore, be exploited in clinical analyses and point-of-care diagnostics for cancer, particularly if computational methods are used to process the data.

1 March 2015 in Translational Materials Research
Verified
Journal Article
Closed access
OCOlivia Carr
Olivia Carr
GGGiovani Gozzi
Giovani Gozzi
LFLucas Fugikawa
Lucas Fugikawa
RFRoberto Mendonça Faria
Roberto Mendonça Faria
DCDante Luis Chinaglia
Dante Luis Chinaglia

2 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LBLeandro B. Borré
Leandro B. Borré
ESEduardo Gomes Rodrigues de Sousa
Eduardo Gomes Rodrigues de Sousa
RGRosane A.S. San Gil
Rosane A.S. San Gil
MBMateus M. Baptista
Mateus M. Baptista
ALAlexandre A. Leitão
Alexandre A. Leitão
TGThiago Frances Guimarães
Thiago Frances Guimarães
Mefloquine (MQ) is an antimalarial medication prescribed to treat or malaria prevention.. When taken by children, vomiting usually occurs, and new doses of medication frequently need to be taken. So, developing pediatric medicines using taste-masked antimalarial drug complexes is mandatory for the success of mefloquine administration. The hypothesis that binding mefloquine to an ion-exchange resin (R) could circumvent the drug’s bitter taste problem was proposed, and solid-state 13C cross-polarization magic angle spinning (CPMAS) NMR was able to follow MQ–R mixtures through chemical shift and relaxation measurements. The nature of MQ–R complex formation could then be determined. Impedimetric electronic tongue equipment also verified the resinate taste-masking efficiency in vitro. Variations in chemical shifts and structure dynamics measured by proton relaxation properties (e.g., T1ρH) were used as probes to follow the extension of mixing and specific interactions that would be present in MQ–R. A significant decrease in T1ρH values was observed for MQ carbons in MQ–R complexes, compared to the ones in MQ (from 100–200 ms in MQ to 20–50 ms in an MQ–R complex). The results evidenced that the cationic resin interacts strongly with mefloquine molecules in the formulation of a 1:1 ratio complex. Thus, 13C CPMAS NMR allowed the confirmation of the presence of a binding between mefloquine and polacrilin in the MQ–R formulation studied.